Exicure, Inc.
IL-1 BETA TARGETING SPHERICAL NUCLEIC ACIDS
Last updated:
Abstract:
The invention in some aspects relates to antisense inhibitors of IL1B and related methods of use. The antisense inhibitors may be formulated as a nanoparticle or other type of three dimensional presentation format.
Status:
Application
Type:
Utility
Filling date:
20 Jun 2019
Issue date:
2 Sep 2021